Clinical trial
Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With…
NCT00468000 · Vericel Corporation, Industry · Completed
Key facts
| NCT number | NCT00468000 |
|---|---|
| Title | Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia |
| Official title | Use of Ixmyelocel-T (Formerly TRC Autologous Bone Marrow Cells) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia |
| Acronym | RESTORE-CLI |
| Lead sponsor | Vericel Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral Arterial Disease |
| Intervention type | Biological |
| Interventions | Ixmyelocel-T, Placebo |
| Enrollment | 86 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | May 1, 2007 |
| Last update posted | May 20, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: